MyAverix Finance MyAverix Finance

BE

Royalty Pharma PLC (RPD)

Royalty Pharma PLC (RPD) is listed on BE. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for RPD

P/E ratio
18.00

Royalty Pharma PLC (RPD) — FAQ

What is RPD's P/E ratio?

The price-to-earnings (P/E) ratio for Royalty Pharma PLC (RPD) is 18.00 (data as of 2026-03-23).

Does Royalty Pharma PLC pay a dividend?

Dividend yield is not available in the current snapshot for Royalty Pharma PLC (RPD). Check the MyAverix Finance app for the latest dividend data.

What exchange is RPD listed on?

RPD is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play